Novartis AG (NVS) शेयर — क्या यह अच्छा व्यवसाय है?

Novartis AG (NVS) शेयर — क्या यह अच्छा व्यवसाय है? — InspectStocks

कमाई कैसे होती है

Prescription medicines

मुकाबला किनसे है

क्या बेचती है6

Entresto
A pill used to treat certain types of chronic heart failure, when the heart cannot pump or fill with blood properly.
Cosentyx
An injection for inflammatory conditions including psoriasis, some forms of arthritis and a chronic skin disease called hidradenitis suppurativa.
Kisqali
A cancer medicine used with hormone treatment for certain types of breast cancer.

3 और दिखाएँ

Kesimpta
A monthly self-injection for adults with relapsing forms of multiple sclerosis, a disease in which the immune system damages nerves.
Pluvicto
An intravenous treatment that delivers radioactive particles to certain prostate cancer cells.
Leqvio
An injection given by a health professional to lower low-density lipoprotein (LDL) cholesterol, a type of fat in the blood.

कौन खरीदता है5

Drug wholesalers buy medicines for resale to pharmacies and healthcare providers.
Retail and specialty pharmacies dispense medicines to patients, including drugs that need special handling.
Hospitals and private health systems buy medicines for treatment in their facilities.

2 और दिखाएँ

Government agencies and government-supported health systems buy or fund medicines for patients.
Insurers and managed-care organizations influence which medicines are covered and reimbursed.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Sales of branded medicines depend on patent rights and regulatory exclusivity; generic or biosimilar competitors can enter after protections expire or are successfully challenged.
2Some medicines depend on licenses, collaborations or other agreements with outside drug developers.
3Manufacturing depends on specialized materials and tightly controlled production processes; some products may have limited alternative suppliers.
4Access to medicines depends on health-authority approval and on insurers or government health systems deciding whether and how much to reimburse.

क्या ग़लत हो सकता है

1Generic competition and patent challenges can reduce sales when drug protections expire or competitors successfully challenge them; Novartis has also faced generic erosion for established medicines.
2Government price controls, Medicare price negotiations, required rebates and insurer coverage decisions can limit the prices Novartis receives or restrict patient access.
3Drug candidates can fail clinical trials or fail to receive approval after years of research and testing, leaving Novartis without a marketable medicine and with development costs already incurred.

पूरे वित्तीय विवरण →

Novartis AG के बारे में

Novartis researches, tests, manufactures and sells prescription medicines in about 120 countries (2025, high). Its research focuses on heart, kidney and metabolic diseases, immune disorders, brain and nerve diseases, and cancer. Net sales were USD 54.532 billion (FY2025, high).

मुख्यालय: Basel, Switzerland
स्थापना: 1996
कर्मचारी: 75,267 (December 31, 2025, high)
सूचीबद्ध: NYSE
वित्त वर्ष का अंत: December 31

Novartis AG की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।

Keep exploring

The themes Novartis is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Highest-graded in Drug Manufacturers General

Graded A or B and worth $2B or more: A first, then the largest.

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

कमाई कैसे होती है

Prescription medicines

मुकाबला किनसे है

क्या बेचती है6

Entresto
A pill used to treat certain types of chronic heart failure, when the heart cannot pump or fill with blood properly.
Cosentyx
An injection for inflammatory conditions including psoriasis, some forms of arthritis and a chronic skin disease called hidradenitis suppurativa.
Kisqali
A cancer medicine used with hormone treatment for certain types of breast cancer.

3 और दिखाएँ

Kesimpta
A monthly self-injection for adults with relapsing forms of multiple sclerosis, a disease in which the immune system damages nerves.
Pluvicto
An intravenous treatment that delivers radioactive particles to certain prostate cancer cells.
Leqvio
An injection given by a health professional to lower low-density lipoprotein (LDL) cholesterol, a type of fat in the blood.

कौन खरीदता है5

Drug wholesalers buy medicines for resale to pharmacies and healthcare providers.
Retail and specialty pharmacies dispense medicines to patients, including drugs that need special handling.
Hospitals and private health systems buy medicines for treatment in their facilities.

2 और दिखाएँ

Government agencies and government-supported health systems buy or fund medicines for patients.
Insurers and managed-care organizations influence which medicines are covered and reimbursed.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Sales of branded medicines depend on patent rights and regulatory exclusivity; generic or biosimilar competitors can enter after protections expire or are successfully challenged.
2Some medicines depend on licenses, collaborations or other agreements with outside drug developers.
3Manufacturing depends on specialized materials and tightly controlled production processes; some products may have limited alternative suppliers.
4Access to medicines depends on health-authority approval and on insurers or government health systems deciding whether and how much to reimburse.

क्या ग़लत हो सकता है

1Generic competition and patent challenges can reduce sales when drug protections expire or competitors successfully challenge them; Novartis has also faced generic erosion for established medicines.
2Government price controls, Medicare price negotiations, required rebates and insurer coverage decisions can limit the prices Novartis receives or restrict patient access.
3Drug candidates can fail clinical trials or fail to receive approval after years of research and testing, leaving Novartis without a marketable medicine and with development costs already incurred.

पूरे वित्तीय विवरण →

Novartis AG के बारे में

मुख्यालय: Basel, Switzerland
स्थापना: 1996
कर्मचारी: 75,267 (December 31, 2025, high)
सूचीबद्ध: NYSE
वित्त वर्ष का अंत: December 31

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है5

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Novartis AG के बारे में

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है5

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Novartis AG के बारे में

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

Big pharma

Novartis AG

वृद्धि और नकदी — 5 में से 5

समय के साथ शेयर भाव और ग्रेड

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है5

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Novartis AG के बारे में

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है5

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Novartis AG के बारे में

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

Big pharma

Novartis AG

पिछला प्रदर्शन

वृद्धि और नकदी — 5 में से 5

समय के साथ शेयर भाव और ग्रेड